Study setting
cancer, Cancer
CANCER, CANCER
This analysis uses data collected as part of a randomized control trial of GC-CCP in Eastern Uganda between September 2021 and April 2022. The pilot study was conducted at Buyinja Health Center IV and Banda Health Center III in Namayingo, a rural community in the Busoga region of Uganda. The selection of the study site was influenced by previous work in this area by our partner institution (Rays of Hope Hospice Jinja; RHHJ) coupled with low CC screening rates observed among women in this district. CC screening with visual inspection (VIA) and thermal therapy are available at both Buyinja and Banda health centers, and from RHHJ which conducts periodic mobile CC screening and thermal therapy “day camps”. Women who need biopsies are sent to Jinja (approximately 90 km from Namayingo), and if cancerous lesions are present, they are referred to the Uganda Cancer Institute, the leading tertiary public cancer care centre located in Kampala.